ANS Biotech is an independent preclinical CRO exclusively dedicated to the in vivo pharmacology of pain.
The company offers its clients a unique combination of exceptional expertise in the fundamentals of pain pharmacology as well as a proven record of R&D program management for new and innovative analgesics. Our mission is to support the drug discovery and development efforts of companies involved in human and animal health, food and nutrition, by offering a broad range of consulting services and a growing list of clinically relevant disease and efficacy models.
In order to support the early stages of drug discovery for its clients, ANS Biotech established a unique in vivo High Throughput Screening tool (ALGOGramTM) that provides a rapid and cost-effective means to systematically explore pain indications for new chemical entities.
The ALGOGramTM is based on a battery of 11 validated models/tests spanning a broad range of pain areas – acute and tonic pain, neuropathic pain, inflammatory pain, post operative pain, and visceral pain. Results generated in the ALGOGramTM are assembled in a summary table format that provides a ready evaluation of a compound for potential efficacy, both in the context of reference drugs and standard measures of behavioral toxicity. The ALGOGramTM can provide a user-friendly pharmacological compound profile in only 3 weeks, facilitating the crucial “GO / NO GO” decisions routinely faced by pharmaceutical companies.
ANS Biotech has not received any reviews.
ANS Biotech has not received any endorsements.